Physician profile
John Robert Lonas
NPI 1902897671
$3,478.11
in general payments reported to CMS, 2019-2025
22 companies · $540 in 2025
The $540 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.52 · 2020: $74.90 · 2021: $94.30 · 2022: $218 · 2023: $561 · 2024: $1,901 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,002.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $2,084.23 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $217.77 | 2022-2025 | Azstarys |
| Pfizer INC. | $194.60 | 2022-2025 | |
| Seqirus USA INC | $129.40 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Collegium Pharmaceutical, INC. | $124.53 | 2025 | Jornay Pm |
| Tris Pharma INC | $101.23 | 2019-2025 | Dyanavel Xr |
| Merck Sharp & Dohme LLC | $95.76 | 2019-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Cranial Technologies, INC | $80.78 | 2020-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $78.01 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $64.02 | 2023-2024 | Flumist Quadrivalent |
| Sanofi Pasteur INC. | $61.44 | 2023-2025 | |
| Acadia Pharmaceuticals INC | $56.39 | 2025 | Daybue |
| Ironshore Pharmaceuticals INC. | $48.01 | 2020-2023 | Jornay Pm |
| Genentech USA, INC. | $30.97 | 2019-2021 | |
| Kaleo, INC. | $23.24 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $16.93 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $16.39 | 2025 | Neffy |
| Organon LLC | $15.13 | 2023 | Nexplanon |
| Sobi, INC | $14.95 | 2022 | |
| Rhodes Pharmaceuticals L.P. | $12.85 | 2019 | |
| Adlon Therapeutics L.P. | $11.48 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lonas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.